Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.
Multiple sclerosis in 2014: Progress in MS-classification, mechanisms and treatment.
Cost-effectiveness analysis of peginterferon beta-1a compared with interferon beta-1a and glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis in the United States.
Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.
Combination therapy in patients with relapsing-remitting multiple sclerosis (MS) CombiRx
Rituximab (marketed as Rituxan), Information
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.
Multiple sclerosis: clinical presentation, diagnosis and treatment.
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
Multiple sclerosis: association with HL-A3.
Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
Receptos to deliver scientific presentation at Digestive Disease Week 2012 about the therapeutic role of RPC1063 in inflammatory bowel disease
Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease.
Extavia Prescribing Information
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
Masitinib in Patients with Progressive or Relapse-Free Secondary Multiple Sclerosis
Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.
Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta-1a (IFN beta-1 a) products administered intramuscularly in healthy male and female volunteers.
Multiple Sclerosis.

Pages